Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Avista buys into solid-state services

by Rick Mullin
January 29, 2018 | A version of this story appeared in Volume 96, Issue 5

Researchers.
Credit: Solid Form Solutions
A still from a Solid Form Solutions video showing the firm's capabilities.

Drug development services firm Avista Pharma Solutions has acquired Solid Form Solutions, a provider of solid-state pharmaceutical chemistry and crystallization services based in Edinburgh, Scotland. Solid Form Solutions provides salt screening and selection, cocrystal and polymorph screening, and crystallization services. For Avista, the purchase follows expansion last year of analytical capabilities in Durham, N.C.; drug substance and product manufacturing in Longmont, Colo.; and microbiology and sterility testing in Agawam, Mass.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.